Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colchicine AF Trial
NCT05459974Phase 3Unknown
- Sponsor
- Stony Brook University
- Start
- Jun 2022
- Primary completion
- Nov 2023
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of colchicine in Atrial fibrillation (AFib), sponsored by Stony Brook University. Status: unknown.
02
Drugs
colchicine
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT05459974.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05459974.